The table below shows PTC THERAPEUTICS, INC.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
$711.20M
-$107.69M
-$158.42M
-$356.65M
-$251.33M
-$194.07M
Capital expenditure
$8.86M
$6.50M
$28.44M
$32.02M
$28.21M
$17.84M
Investing cash flow
-$861.98M
$44.18M
-$176.74M
$290.18M
$219.18M
-$561.55M
Dividends paid
-
-
-
-
-
PTCT operating cash flow (10-K history)
PTC THERAPEUTICS, INC. reported operating cash flow of $711.20M for fiscal year 2025. That is up 760.4% from -$107.69M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$103.57M (FY 2016) to $711.20M. Figures come from the company's audited annual reports as filed with the SEC.
